Johnson & Johnson SEC filings JNJ
Johnson & Johnson has 1,000 filings in SEC EDGAR's recent list, going back to Aug 2, 2018. Its latest annual report, Form ARS, was filed on Mar 11, 2026 for the period ended Dec 28, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 21, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| N-PX | Filing | Aug 11, 2026 | Jun 30, 2026 |
| 11-K | Employee savings plan report | Jun 25, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 25, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2026 | — |
| N-PX | Filing | Aug 26, 2025 | Jun 30, 2025 |
| 11-K | Employee savings plan report | Jun 24, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 24, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2025 | — |
| UPLOAD | Letter from the SEC | May 2, 2025 | — |
| CORRESP | Letter to the SEC | Apr 23, 2025 | — |
| PX14A6G | Bowyer research - px14a6g | Apr 23, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2025 | — |
| PX14A6G | Filing | Mar 20, 2025 | — |
| DFAN14A | Filing | Mar 7, 2025 | — |
| CERT | Nyse certification | Feb 28, 2025 | — |
| 8-A12B | Filing | Feb 26, 2025 | — |
| DFAN14A | Filing | Feb 25, 2025 | — |
| DFAN14A | Filing | Jan 22, 2025 | — |
| DFAN14A | Filing | Jan 13, 2025 | — |
| 25-NSE | Delisting notice | Nov 6, 2024 | — |
| N-PX | Filing | Aug 29, 2024 | Jun 30, 2024 |
| 11-K/A | Filing | Jun 25, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 24, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 24, 2024 | Dec 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2024 | — |
| CERT | Nyse certification | May 21, 2024 | — |
| 8-A12B | Filing | May 20, 2024 | — |
| 25-NSE | Delisting notice | May 20, 2024 | — |
| DFAN14A | Filing | Apr 5, 2024 | — |
| PX14A6G | National legal and policy center - px14a6g | Mar 27, 2024 | — |
| DFAN14A | Filing | Feb 15, 2024 | — |
| DFAN14A | Filing | Jan 29, 2024 | — |
| DFAN14A | Filing | Jan 9, 2024 | — |
| DFAN14A | Filing | Jan 8, 2024 | — |
| SC TO-I/A | Filing | Aug 23, 2023 | — |
| 425 | Filing | Aug 23, 2023 | — |
| SC TO-I/A | Filing | Aug 21, 2023 | — |
| 425 | Filing | Aug 21, 2023 | — |
| 425 | Filing | Aug 18, 2023 | — |
| 425 | Filing | Aug 17, 2023 | — |
| SC TO-I/A | Filing | Aug 17, 2023 | — |
| 425 | Filing | Aug 17, 2023 | — |
| 425 | Filing | Aug 17, 2023 | — |
| 425 | Filing | Aug 16, 2023 | — |
| 425 | Filing | Aug 15, 2023 | — |
| 425 | Filing | Aug 14, 2023 | — |
| 425 | Filing | Aug 11, 2023 | — |
| 425 | Filing | Aug 10, 2023 | — |
| 425 | Filing | Aug 9, 2023 | — |
| 425 | Filing | Aug 8, 2023 | — |
| 425 | Filing | Aug 7, 2023 | — |
| 425 | Filing | Aug 4, 2023 | — |
| 425 | Filing | Aug 3, 2023 | — |
| 425 | Filing | Aug 3, 2023 | — |
| SC TO-I/A | Filing | Aug 3, 2023 | — |
| 425 | Filing | Aug 2, 2023 | — |
| 425 | Filing | Aug 1, 2023 | — |
| 425 | Filing | Jul 31, 2023 | — |
| 425 | Filing | Jul 31, 2023 | — |
| 425 | Filing | Jul 28, 2023 | — |
| 425 | Filing | Jul 28, 2023 | — |
| 425 | Filing | Jul 28, 2023 | — |
| 425 | Filing | Jul 28, 2023 | — |
| 425 | Filing | Jul 27, 2023 | — |
| 425 | Filing | Jul 27, 2023 | — |
| 425 | Filing | Jul 26, 2023 | — |
| 425 | Filing | Jul 26, 2023 | — |
| 425 | Filing | Jul 25, 2023 | — |
| 425 | Filing | Jul 25, 2023 | — |
| 425 | Filing | Jul 25, 2023 | — |
| 425 | Filing | Jul 25, 2023 | — |
| 425 | Filing | Jul 25, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| SC TO-I | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 24, 2023 | — |
| 425 | Filing | Jul 20, 2023 | — |
| 425 | Filing | Jul 20, 2023 | — |
| 425 | Filing | Jul 20, 2023 | — |
| 425 | Filing | Jul 20, 2023 | — |
| 425 | Filing | Jul 20, 2023 | — |
| 11-K | Employee savings plan report | Jun 26, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 26, 2023 | Dec 31, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 24, 2023 | — |
| PX14A6G | Filing | Apr 12, 2023 | — |
| PX14A6G | Filing | Apr 10, 2023 | — |
| PX14A6G | Filing | Mar 22, 2023 | — |
| SC TO-T/A | Filing | Dec 22, 2022 | — |
| SC TO-T/A | Filing | Dec 19, 2022 | — |
| SC TO-T/A | Filing | Dec 15, 2022 | — |
| SC TO-T/A | Filing | Dec 14, 2022 | — |
| SC TO-T/A | Filing | Dec 8, 2022 | — |
| SC TO-T | Filing | Nov 15, 2022 | — |
| SC TO-C | Filing | Nov 7, 2022 | — |
| SC TO-C | Filing | Nov 3, 2022 | — |
| SC TO-C | Filing | Nov 1, 2022 | — |
| SC TO-C | Filing | Nov 1, 2022 | — |
| 11-K | Employee savings plan report | Jun 16, 2022 | Jun 14, 2022 |
| 11-K | Employee savings plan report | Jun 16, 2022 | Jun 14, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 26, 2022 | — |
| PX14A6G | Filing | Apr 1, 2022 | — |
| PX14A6G | Filing | Mar 31, 2022 | — |
| PX14A6G | Filing | Mar 29, 2022 | — |
| PX14A6G | Filing | Mar 22, 2022 | — |
| PX14A6G | Filing | Mar 17, 2022 | — |
| 25-NSE | Delisting notice | Jan 20, 2022 | — |
| 13F-NT | Filing | Aug 3, 2021 | Jun 30, 2021 |
| 11-K | Employee savings plan report | Jun 17, 2021 | Jun 17, 2021 |
| 11-K | Employee savings plan report | Jun 17, 2021 | Jun 17, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 27, 2021 | — |
| UPLOAD | Letter from the SEC | May 27, 2021 | — |
| 13F-NT | Filing | May 7, 2021 | Mar 31, 2021 |
| CORRESP | Letter to the SEC | May 4, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2021 | — |
| PX14A6G | Filing | Apr 14, 2021 | — |
| PX14A6G | Filing | Mar 29, 2021 | — |
| PX14A6G | Filing | Mar 26, 2021 | — |
| PX14A6G | Filing | Mar 24, 2021 | — |
| PX14A6G | Filing | Mar 22, 2021 | — |
| 13F-NT | Filing | Feb 9, 2021 | Dec 31, 2020 |
| 13F-NT | Filing | Nov 3, 2020 | Sep 30, 2020 |
| SC TO-T/A | Filing | Oct 1, 2020 | — |
| SC TO-T/A | Filing | Sep 23, 2020 | — |
| SC TO-T/A | Filing | Sep 15, 2020 | — |
| SC TO-T/A | Filing | Sep 4, 2020 | — |
| SC TO-T | Filing | Sep 2, 2020 | — |
| SC TO-C | Filing | Aug 20, 2020 | — |
| SC TO-C | Filing | Aug 19, 2020 | — |
| 13F-NT | Filing | Aug 12, 2020 | Jun 30, 2020 |
| 11-K | Employee savings plan report | Jun 18, 2020 | Dec 31, 2019 |
| 11-K | Employee savings plan report | Jun 18, 2020 | Dec 31, 2019 |
| SD | Specialized disclosure (conflict minerals) | May 28, 2020 | — |
| 13F-NT | Filing | May 13, 2020 | Mar 31, 2020 |
| PX14A6G | Filing | Mar 16, 2020 | — |
| 13F-NT | Filing | Feb 14, 2020 | Dec 31, 2019 |
| 25-NSE | Delisting notice | Nov 6, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2019 | — |
| CORRESP | Letter to the SEC | Aug 22, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2019 | — |
| CORRESP | Letter to the SEC | Jul 24, 2019 | — |
| 15-15D | Filing | Jun 25, 2019 | — |
| 11-K | Employee savings plan report | Jun 25, 2019 | Dec 31, 2018 |
| 11-K | Employee savings plan report | Jun 25, 2019 | Dec 31, 2018 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2019 | — |
| PX14A6G | Filing | Mar 19, 2019 | — |
Showing 161 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JNJ (NYSE)
- Fiscal year ends
- January 3
- Incorporated in
- NJ
- Headquarters
- New Brunswick, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 200406
- Former names
- JOHNSON & JOHNSON ET AL (until Jan 23, 1996)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.